Attackers are actively exploiting path traversal and SQL injection in Langflow, LangGraph, and LangChain — below where your ...

AURORA targets a high-unmet-need population: metastatic non-squamous NSCLC with progression on pembrolizumab and platinum ...

Phase 3 clinical trial will evaluate aglatimagene besadenovec plus valacyclovir in combination with continued pembrolizumab ...

Attackers are using multiple channels — including GitHub, YouTube, and VirusTotal — to build an illusion of trust to spread ...

This cybersecurity leader, known for its global threat prevention platforms, reported significant insider selling in its ...

Because Krea relinquishes centralized control over the downstream deployment of its open weights, the contract legally binds ...

Claude Code dynamic workflows are now generally available on all paid plans, including Pro for the first time. The feature writes its own orchestration scripts and coordinates up to 1,000 parallel ...

Multi-cloud sounds promising on paper: more flexibility, less vendor lock-in, and the freedom to use the 'best' service from ...

(Nasdaq: EXEL) today announced results from the final analysis of the dual primary endpoint of overall survival (OS) in the subset of patients without active liver metastases (non-liver metastases, ...

This week, the United States celebrates 250 years as a nation, a nation that was a beacon of hope for many who immigrated or ...

Approval establishes sacituzumab govitecan as a first-line option across PD-L1 strata, including monotherapy when checkpoint inhibitors are unsuitable and combination therapy for PD-L1 CPS ≥10 tumors.